The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury

Area of Science:

• Radiation biology
• Molecular and cellular mechanisms of cell death
• Immunology

Background:

• Acute radiation exposure causes significant cell death in rapidly dividing tissues like bone marrow and the gastrointestinal tract.
• The precise molecular pathways driving radiation-induced pathology are not fully understood.
• The inflammasome pathway and its role in radiation injury require further elucidation.

Purpose of the Study:

• To investigate the role of the double-stranded DNA sensor AIM2 in the cellular and molecular response to ionizing radiation.
• To determine if AIM2 deficiency confers protection against radiation-induced gastrointestinal syndrome and hematopoietic failure.
• To elucidate the mechanism by which AIM2 contributes to radiation-induced cell death.

Main Methods:

• Utilized knockout mice lacking the AIM2 gene.
• Administered subtotal and total body irradiation to assess gastrointestinal syndrome and hematopoietic failure.
• Analyzed cell death pathways, including caspase-1 activation, in intestinal and bone marrow cells.
• Investigated the localization and function of AIM2 in response to radiation-induced DNA damage.

Main Results:

• Mice deficient in AIM2 exhibited significant protection against radiation-induced gastrointestinal syndrome and hematopoietic failure.
• AIM2 was found to mediate caspase-1-dependent cell death in intestinal epithelial and bone marrow cells following double-strand DNA breaks.
• AIM2 senses DNA damage within the nucleus, leading to inflammasome activation and subsequent cell death.
• This mechanism was also observed in response to DNA breaks induced by chemotherapeutic agents.

Conclusions:

• AIM2 plays a critical role in mediating cell death in response to ionizing radiation and chemotherapeutic agents.
• AIM2 acts as a sensor of DNA double-strand breaks, initiating inflammasome activation and cell death.
• Targeting AIM2 presents a potential therapeutic strategy for mitigating the adverse effects of radiation exposure.